Journals / Türk Psikiyatri Dergisi / 2019 / Cilt: 30 - Sayı: 2

Manic Shift Due to the Use of Bupropion in Bipolar Depression: Two Case Reports

Bipolar Depresyonda Bupropiyon Kullanımına Bağlı Manik Kayma: İki Olgu Sunumu

Pages
145–148
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Significant improvement was noted shortly after bupropion was discontinued and antipsychotic treatment was initiated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bupropion is a selective norepinephrine and dopamine reuptake inhibitor.
📊
Key Findings & Data:The first was a 43-year old female patient.
💡
Conclusion & Impact:Significant improvement was noted shortly after bupropion was discontinued and antipsychotic treatment was initiated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bupropion is a selective norepinephrine and dopamine reuptake inhibitor. It is used in the treatment of depression and nicotine addiction. When compared to the other antidepressants, bupropion has a relatively lower risk of triggering shift to hypomania or mania in bipolar depression treatment. Here we report two cases of bipolar depression patients with manic shift when bupropion was used as an adjunct to mood stabilizer treatment. The first was a 43-year old female patient. Manic symptoms occurred after bupropion was added to lithium and quetiapine treatment for bipolar disorder (BD) depressive episode. Her manic symptoms regressed rapidly after discontinuing bupropion treatment. The second patient was a 26-year old male on lithium and valproate therapy with a BD diagnosis. After bupropion was added to his treatment for depressive symptoms, psychotic mania ensued and he had to be admitted to the hospital. Significant improvement was noted shortly after bupropion was discontinued and antipsychotic treatment was initiated.

Özet

Bupropiyon seçici norepinefrin ve dopamin geri alım inhibitörüdür. Depresyon tedavisinin yanı sıra nikotin bağımlılığının tedavisinde de kullanılmaktadır. Diğer antidepresan tedavilere göre bipolar bozuklukta depresif dönemde kullanılan bupropiyonun manik ya da hipomanik kaymayı tetikleme riski daha düşüktür. Bu yazıda duygudurum düzenleyici tedaviye eklenen bupropiyon sonrası manik kayma gözlenen iki olgu sunulmuştur. Birincisi 43 yaşında kadın hastadır. Bipolar bozukluk depresif dönem tanısıyla kullanmakta olduğu lityum ve ketiapin tedavisine bupropiyon eklendikten sonra manik belirtiler ortaya çıkmıştır. Bupropiyon kesilerek ayaktan takibe alınmış ve hızlıca belirtileri kaybolmuştur. İkincisi 26 yaşında erkek hastadır. Bilinen bipolar bozukluk tanısı olan hasta depresif semptomları nedeniyle kullanmakta olduğu lityum ve valproat tedavisine bupropiyon eklendikten sonra psikotik özellikli manik belirtileri nedeniyle yatırılarak tedavi altına alınmıştır. Bupropiyon kesilip antipsikotik tedavi düzenlendikten kısa süre sonra belirtilerinde belirgin düzelme gözlenmiştir.

🔖

Cite This Article

KILIÇ, E. K., GÖRGÜLÜ, Y., ÇINAR, R. K., SÖNMEZ, M. B. (2019). Manic Shift Due to the Use of Bupropion in Bipolar Depression: Two Case Reports. Türk Psikiyatri Dergisi, Cilt: 30 - Sayı: 2, 145–148. https://ajindex.com/articles/78766

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Bittman BJ, Young RC (1991) Mania in an elderly man treated with bupropion. The Am J Psychiatry 148: 541. Bottlender R, Rudolf D, Straub A (2001) Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord 63: 79–84.
  2. Erfurth A, Michael N, Stadland C ve ark. (2002) Bupropion as add-in strategyin difficult-to-treat bipolar depressive disorder. Neuropsychobiology 45: 33–6.
  3. Fogelson DL, Bystritsky A, Pasnau R (1992) Bupropion in the treatment of bipolar disorders: the same old story? J Clin Psychiatry 53: 443–6. Giasson-Gariépy K, Jutras-Aswad D (2013) A case of hypomania during nicotine cessation treatment with bupropion. Addiction Science & Clinical Practice 8: 22. Goldberg JF, Truman CJ (2003) Antidepressant-induced mania: an overview of current controversies. Bipolar Disorders 5: 407-20.
  4. Goldberg JF, Whiteside JE (2002) The association between substance abuse and antidepressant-induced mania in bipolar disorder: a preliminary study. J Clin Psychiatry 63: 791–5.
  5. Goren JL, Levin GM (2000) Mania with bupropion: a dose-related phenomenon? Ann Pharmacother 34:619–21.
  6. HenryC, Sorbara F, Lacoste J (2001) Antidepressant induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 62: 249–55.
  7. Hussain H, Butt MA (2008) Bupropion-induced hypomania in a patient with unipolar depression. The Aust N Z J Psychiatry 42: 746. Leverich GS, Altshuler LL, Frye MA ve ark. (2006) Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers Am J Psychiatry 163: 232–9.
  8. Li DJ, Tseng PT, Chen YW ve ark. (2016) Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as OtherA ntidepressants. A Meta-Analysis Following the PRISMA Guidelines. Medicine 95: e3165. Liu B, Zhang Y, Fang H ve ark. (2017) Efficacy and safety of long-term antidepressant treatment for bipolar disorders- A meta-analysis of randomized controlled trials. J Affect Disord 223: 41-8.
  9. Masand P, Stern TA (1993) Bupropion and secondary mania. Is there a relationship? Annf Clin Psychiatry 5: 271–4.
  10. Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549–50.
  11. Post RM, Altshuler LL, Frye MA ve ark. (2001) Rate of switch in bipolar patients p